US Markets for Drug Delivery

MRG Table of Contents

TABLE OF CONTENTS

LIST OF EXHIBITS

EXECUTIVE SUMMARY

METHODOLOGY

1.0 DRUG DELIVERY OVERVIEW

1.1 Market Overview

1.2 Market Analysis

1.2.1 Routes of Administration

1.2.1.1 Injectable Devices

1.2.1.2 Infusion Pumps

1.2.1.3 Inhalable Devices

1.2.1.4 Implantable Delivery

1.2.1.5 Transdermal Delivery

1.2.1.6 Transmucosal Delivery

1.2.1.7 Oral Delivery

1.2.1.8 Emerging Technologies

1.2.2 Market Forecast

1.2.2.1 Drug Delivery Devices

1.2.2.2 Drug Delivery Technology

1.2.3 Market Trends

1.2.3.1 Market Drivers

1.2.3.2 Market Limiters

1.3 Competitive Analysis

2.0 INJECTABLE DEVICES

2.1 Market Overview

2.2 Market Analysis

2.2.1 Syringes Market Forecast

2.2.1.1 Standard Multipurpose

2.2.1.2 Safety Multipurpose

2.2.2 Injection Pens Market Forecast

2.2.2.1 Reusable Pens

2.2.2.2 Disposable Pens

2.2.3 Autoinjectors Market Forecast

2.2.4 Needle-Free Injectors Market Forecast

2.2.5 Market Drivers and Limiters

2.2.5.1 Market Drivers

2.2.5.2 Market Limiters2.3 Competitive Analysis

3.0 INFUSION PUMPS

3.1 Market Overview

3.2 Market Analysis

3.2.1 Insulin Pumps Market Forecast

3.2.1.1 Types of Diabetes

3.2.2 Implantable Infusion Pumps Market Forecast

3.2.2.1 Programmable and Constant Flow

3.2.3 Volumetric Infusion Pumps Market Forecast

3.2.3.1 Single-Channel and Multichannel Pumps

3.2.4 Electronic Ambulatory Infusion Pumps Market Forecast

3.2.4.1 Hospital and Alternative Care Sales

3.2.5 Disposable Ambulatory Infusion Pumps Market Forecast

3.2.5.1 Postoperative Pumps and Alternative Care Site Disposable Pumps

3.2.6 Enteral Feeding Pumps Market Forecast

3.2.6.1 Enteral Pump Site and Enteral Pump Users

3.2.7 Syringe Infusion Pumps Market Forecast

3.2.7.1 High- and Low-End Syringe Pumps

3.3 Market Drivers and Limiters

3.3.1.1 Market Drivers

3.3.1.2 Market Limiters

3.4 Competitive Analysis

4.0 INHALABLE DEVICES

4.1 Market Overview

4.2 Market Analysis

4.2.1 Asthma and Chronic Obstructive Pulmonary Disorder (COPD)

4.2.2 Metered Dose Inhalers Market Forecast

4.2.2.1 Standard Metered Dose Inhalers

4.2.2.2 CFC-Free Metered Dose Inhalers

4.2.2.3 Breath-Actuated Metered Dose Inhalers

4.2.3 Dry Powder Inhalers Market Forecast

4.2.3.1 Direct Haler

4.2.4 Nebulizers Market Forecast

4.2.5 Market Drivers and Limiters

4.2.5.1 Market Drivers

4.2.5.2 Market Limiters

4.3 Competitive Analysis

4.3.1 Inhalation Formulation Competitors

5.0 IMPLANTABLE DELIVERY

5.1 Market Overview

5.2 Market Analysis

5.2.1 Surgical Implants Market Forecast

5.2.1.1 Drug-Eluting Stents

5.2.1.2 Implantable Contraceptives5.2.1.3 DUROS Technologies

5.2.2 Injectable Depot Systems Market Forecast

5.2.2.1 Eligard

5.2.2.2 Risperdal Consta

5.2.2.3 DepoCyt

5.2.3 Market Drivers and Limiters

5.2.3.1 Market Drivers

5.2.3.2 Market Limiters

5.3 Competitive Analysis

6.0 TRANSDERMAL DELIVERY

6.1 Market Overview

6.2 Market Analysis

6.2.1 Patches Market Forecast

6.2.2 Topical Market Forecast

6.2.3 Iontophoresis Market Forecast

6.2.4 Market Drivers and Limiters

6.2.4.1 Market Drivers

6.2.4.2 Market Limiters

6.3 Competitive Analysis

7.0 TRANSMUCOSAL DELIVERY

7.1 Market Overview

7.2 Market Analysis

7.2.1 Oral Market Forecast

7.2.2 Nasal Market Forecast

7.2.2.1 Nasal Spray Device and Nasal Spray Technology

7.2.3 Market Drivers and Limiters

7.2.3.1 Market Drivers

7.2.3.2 Market Limiters

7.3 Competitive Analysis

8.0 ORAL DELIVERY

8.1 Market Overview

8.2 Market Analysis

8.2.1 Sustained Release Market Forecast

8.2.2 Fast-Dissolve Market Forecast

8.2.3 Market Drivers and Limiters

8.2.3.1 Market Drivers

8.2.3.2 Market Limiters

8.3 Competitive Analysis

9.0 EMERGING TECHNOLOGY

9.1 Advanced Drug Delivery Systems

9.1.1 Solubilization

9.2 Inhalable Technology

9.2.1 Inhaled Insulin

9.2.1.1 Market Analysis9.3 Implantable Technology

9.3.1 DUROS technologies

9.3.2 Microchip Drug Delivery Systems

9.4 Transdermal Technology

9.4.1 Microneedle Patches

9.4.2 Ultrasonic

9.5 Transmucosal Technology

9.5.1 Nasal

9.5.2 Oral

9.6 Oral Technology

9.7 Emerging Competitors

APPENDIX A: MRG ACRONYMS AND INITIALISMS

APPENDIX B: GLOSSARY OF TERMSMRG List of Exhibits

Executive Summary

Exhibit ES-1: Drug Delivery Market, US, 2003¯2009

Exhibit ES-2: Drug Delivery Market, Segmented by Route of Delivery, US, 2004

Exhibit ES-3: Drug Delivery Market, Segmented by Device and Technology, US, 2003¯2009

Exhibit ES-4: Injectable Delivery Market, Segmented by Type, US, 2004 and 2009

Exhibit ES-5: Infusion Pump Market, Segmented by Type, US, 2004

Exhibit ES-6: Inhalable Delivery Market, US, 2003¯2009

Exhibit ES-7: DES Market, US, 2003¯2009

Exhibit ES-8: Transdermal Delivery Market, US, 2003¯2009

Exhibit: ES-9: Nasal Delivery Market, Segmented by Drug and Device, as Percentage of Total, US, 2003¯2009

Exhibit ES-10: Oral Delivery Market, US, 2003¯2009

Exhibit ES-11: Insulin-Dependent Diabetics, Segmented by Route of Insulin Delivery, US, 2009

Exhibit ES-12: Companies Covered in US Markets for Drug Delivery 2005 (Devices)

Exhibit ES-13: Companies Covered in US Markets for Drug Delivery 2005 (Technology)

Exhibit ES-14: Leading Competitors in the Drug Delivery Device Market, US, 2004

Chapter 1: Drug Delivery Overview

Exhibit 1-1: Drug Delivery Market, US, 2003�E009

Exhibit 1-2: Drug Delivery Market, Device and Technology, US, 2004

Exhibit 1-3: Drug Delivery Market, Segmented by Route of Delivery, US, 2004

Exhibit 1-4: Drug Delivery Market, Technology and Device, as a Percentage of US, 2003-009 (Tabular Format)

Exhibit 1-5: Drug Delivery Market, Technology and Device, as a Percentage of US, 2003-009 (Graphical Format)

Exhibit 1-6: Drug Delivery Device Market, Segmented by Route of Delivery, US, 2003-009 (Tabular Format)

Exhibit 1-7: Drug Delivery Device Market, Segmented by Route of Delivery, US, 2003-009 (Graphical Format)

Exhibit 1-8: Drug Delivery Technology Market, Segmented by Route of Delivery, US, 2003-009 (Tabular Format)

Exhibit 1-9: Drug Delivery Technology Market, Segmented by Route of Delivery, US, 2003-009 (Graphical Format)

Exhibit 1-10: Drivers and Limiters of the Drug Delivery Market, US

Exhibit 1-11: Leading Competitors in the Drug Delivery Market, Segmented by Route of Delivery, US, 2004

Exhibit 1-12: Leading Competitors in the Drug Delivery Market, US, 2004

Chapter 2: Injectable Devices

Exhibit 2-1: Injectable Device Market, US, 2003-009

Exhibit 2-2: Injectable Device Market, Segmented by Type, US, 2003-009 (Tabular Format)

Exhibit 2-3: Injectable Device Market, Segmented by Type, US, 2003-009 (Graphical Format)

Exhibit 2-4: Injectable Device Units, Segmented by Type, US, 2003-009

Exhibit 2-5: Injectable Device Units, Segmented by Type, as a Percentage of Total, US, 2003-009

Exhibit 2-6: Syringe Market, US, 2003-009 (Tabular Format)

Exhibit 2-7: Syringe Market, US, 2003-009 (Graphical Format)

Exhibit 2-8: Syringe Market, Segmented by Type, US, 2003-009 (Tabular Format)

Exhibit 2-9: Syringe Market, Segmented by Type, US, 2003-009 (Graphical Format)

Exhibit 2-10: Standard Multipurpose Syringe Market, US, 2003-009 (Tabular Format)

Exhibit 2-11: Standard Multipurpose Syringe Market, US, 2003-009 (Graphical Format)

Exhibit 2-12: Safety Multipurpose Syringe Market, US, 2003-009 (Tabular Format)

Exhibit 2-13: Safety Multipurpose Syringe Market, US, 2003-009 (Graphical Format)

Exhibit 2-14: Injection Pen Market, US, 2003-009 (Tabular Format)

Exhibit 2-15: Injection Pen Market, US, 2003-009 (Graphical Format)

Exhibit 2-16: Injection Pen Market, Segmented by Type, US, 2003-009 (Tabular Format)

Exhibit 2-17: Injection Pen Market, Segmented by Type, US, 2003-009 (Graphical Format)

Exhibit 2-18: Reusable Injection Pen Market, US, 2003-009 (Tabular Format)

Exhibit 2-19: Reusable Injection Pen Market, US, 2003-009 (Graphical Format)

Exhibit 2-20: Disposable Injection Pen Market, US, 2003-009 (Tabular Format)

Exhibit 2-21: Disposable Injection Pen Market, US, 2003-009 (Graphical Format)

Exhibit 2-22: Autoinjector Market, US, 2003-009 (Tabular Format)

Exhibit 2-23: Autoinjector Market, US, 2003-009 (Graphical Format)

Exhibit 2-24: Needle-Free Injector Market, US, 2003-009 (Tabular Format)

Exhibit 2-25: Needle-Free Injector Market, US, 2003-009 (Graphical Format)

Exhibit 2-26: Drivers and Limiters of the Injectable Devices Market, US

Exhibit 2-27: Leading Competitors in the Injectable Device Market, by Segment, US, 2004

Exhibit 2-28: Leading Competitors in the Injectable Device Market, US, 2004

Chapter 3: Infusion Pumps

Exhibit 3-1: Infusion Pump Market, US, 2003-009

Exhibit 3-2: Infusion Pump Market, Segmented by Type, US, 2003-009 (Tabular Format)

Exhibit 3-3: Infusion Pump Market, Segmented by Type, US, 2003-009 (Graphical Format)

Exhibit 3-4: Infusion Pump Units, Segmented by Type, US, 2003-009 (Tabular Format)

Exhibit 3-5: Infusion Pump Units, Segmented by Type, US, 2003-009 (Graphical Format)

Exhibit 3-6: Insulin Pump Market, US, 2003-009 (Tabular Format)

Exhibit 3-7: Insulin Pump Market, US, 2003-009 (Graphical Format)

Exhibit 3-8: Implantable Infusion Pump Market, US, 2003-009 (Tabular Format)

Exhibit 3-9: Implantable Infusion Pump Market, US, 2003-009 (Graphical Format)

Exhibit 3-10: Programmable Implantable Infusion Pump Market, US, 2003-009

Exhibit 3-11: Constant Flow Implantable Infusion Pump Market, US, 2003-009

Exhibit 3-12: Implantable Infusion Pump Market, Segmented by Type, US, 2003-009 (Tabular Format)

Exhibit 3-13: Implantable Infusion Pump Market, Segmented by Type, US, 2003-009 (Graphical Format)

Exhibit 3-14: Volumetric Infusion Pump Market, US, 2003-009 (Tabular Format)

Exhibit 3-15: Volumetric Infusion Pump Market, US, 2003-009 (Graphical Format)

Exhibit 3-16: Electronic Ambulatory Infusion Pump Market, US, 2003-009 (Tabular Format)

Exhibit 3-17: Electronic Ambulatory Infusion Pump Market, US, 2003-009 (Graphical Format)

Exhibit 3-18: Electronic Ambulatory Infusion Pump Sales, Segmented by Facility, US, 2003-009 (Tabular Format)

Exhibit 3-19: Electronic Ambulatory Infusion Pump Sales, Segmented by Facility, US, 2003-009 (Graphical Format)

Exhibit 3-20: Disposable Ambulatory Infusion Pump Market, US, 2003-009 (Tabular Format)

Exhibit 3-21: Disposable Ambulatory Infusion Pump Market, US, 2003-009 (Graphical Format)

Exhibit 3-22: Disposable Ambulatory Infusion Pump Market, Segmented by Usage, US, 2003-009 (Tabular Format)

Exhibit 3-23: Disposable Ambulatory Infusion Pump Market, Segmented by Usage, US, 2003-009 (Graphical Format)

Exhibit 3-24: Postoperative Disposable Ambulatory Infusion Pump Market, US, 2003-009

Exhibit 3-25: Alternative Care Disposable Ambulatory Infusion Pump Market, US, 2003-009

Exhibit 3-26: Enteral Feeding Pump Market, US, 2003-009 (Tabular Format)

Exhibit 3-27: Enteral Feeding Pump Market, US, 2003-009 (Graphical Format)

Exhibit 3-28: Enteral Feeding Pump Market, Segmented by Location and User, US, 2004

Exhibit 3-29: Syringe Infusion Pump Market, US, 2003-009 (Tabular Format)

Exhibit 3-30: Syringe Infusion Pump Market, US, 2003-009 (Graphical Format)

Exhibit 3-31: High-End Syringe Infusion Pump Market, US, 2003-009

Exhibit 3-32: Low-End Syringe Infusion Pump Market, US, 2003-009

Exhibit 3-33: Syringe Pumps, Segmented by Type, US, 2003-009 (Tabular Format)

Exhibit 3-34: Syringe Pumps, Segmented by Type US, 2003-009 (Graphical Format)

Exhibit 3-35: Drivers and Limiters of the Infusion Pump Market, US

Exhibit 3-36: Leading Competitors in the Infusion Pump Market, by Segment, US, 2004

Exhibit 3-37: Leading Competitors in the Infusion Pump Market, US, 2004

Chapter 4: Inhalable Devices

Exhibit 4-1: Inhalable Device Market, US, 2003-009

Exhibit 4-2: Inhalable Device Market, Segmented by Type, US, 2003-009 (Tabular Format)

Exhibit 4-3: Inhalable Device Market, Segmented by Type, US, 2003-009 (Graphical Format)

Exhibit 4-4: Inhalable Device Units, Segmented by Type, US, 2003-009 (Tabular Format)

Exhibit 4-5: Inhalable Device Units, Segmented by Type, US, 2003-009 (Graphical Format)

Exhibit 4-6: MDI Market, US, 2003-009 (Tabular Format)

Exhibit 4-7: MDI Market, US, 2003-009 (Graphical Format)

Exhibit 4-8: DPI Market, US, 2003-009 (Tabular Format)

Exhibit 4-9: DPI Market, US, 2003-009 (Graphical Format)

Exhibit 4-10: Nebulizer Market, US, 2003-009 (Tabular Format)

Exhibit 4-11: Nebulizer Market, US, 2003-009 (Graphical Format)

Exhibit 4-12: Drivers and Limiters of the Inhalable Device Market, US

Exhibit 4-13: Leading Competitors in the Inhalable Device Market, by Segment, US, 2004

Exhibit 4-14: Leading Competitors in the Inhalable Device Market, US, 2004

Chapter 5: Implantable Delivery

Exhibit 5-1: Implantable Delivery Market, US, 2003-009

Exhibit 5-2: Implantable Delivery Market, Segmented by Type, US, 2003-009 (Tabular Format)

Exhibit 5-3: Implantable Delivery Market, Segmented by Type, US, 2003-009 (Graphical Format)

Exhibit 5-4: DES Market, US, 2003-009 (Tabular Format)

Exhibit 5-5: DES Market, US, 2003-009 (Graphical Format)

Exhibit 5-6: Injectable Depot System Market, US, 2003-009 (Tabular Format)

Exhibit 5-7: Injectable Depot System Market, US, 2003-009 (Graphical Format)

Exhibit 5-8: Eligard Market, US, 2003-009 (Tabular Format)

Exhibit 5-9: Eligard Market, US, 2003-009 (Graphical Format)

Exhibit 5-10: Risperdal Consta Market, US, 2003-009 (Tabular Format)

Exhibit 5-11: Risperdal Consta Market, US, 2003-009 (Graphical Format)

Exhibit 5-12: Drivers and Limiters of the Implantable Delivery Market, US

Exhibit 5-13: Leading Competitors in the DES Market, US, 2004 (Tabular Format)

Exhibit 5-14: Leading Competitors in the DES Market, US, 2004 (Graphical Format)

Chapter 6: Transdermal Delivery

Exhibit 6-1: Transdermal Delivery Market, US, 2003-009

Exhibit 6-2: Transdermal Device Market, Segmented by Type, US, 2003-009 (Tabular Format)

Exhibit 6-3: Transdermal Device Market, Segmented by Type, US, 2003-009 (Graphical Format)

Exhibit 6-4: Transdermal Patch Market, US, 2003-009 (Tabular Format)

Exhibit 6-5: Transdermal Patch Market, US, 2003-009 (Graphical Format)

Exhibit 6-6: Topical Market, US, 2003-009 (Tabular Format)

Exhibit 6-7: Topical Market, US, 2003-009 (Graphical Format)

Exhibit 6-8: Iontophoresis Market, US, 2003-009 (Tabular Format)

Exhibit 6-9: Iontophoresis Market, US, 2003-009 (Graphical Format)

Exhibit 6-10: Patch Technologies, as Percentage of Total, US, 2003-009

Exhibit 6-11: Drivers and Limiters of the Transdermal Market, US

Exhibit 6-12: Leading Competitors in the Transdermal Patch Market, US, 2004 (Tabular Format)

Exhibit 6-13: Leading Competitors in the Transdermal Patch Market, US, 2004 (Graphical Format)

Chapter 7: Transmucosal Delivery

Exhibit 7-1: Transmucosal Delivery Market, US, 2003-009

Exhibit 7-2: Nasal Transmucosal Market, US, 2003-009

Exhibit 7-3: Nasal Transmucosal Market, Segmented by Usage, US, 2003-009

Exhibit 7-4: Nasal Transmucosal Market, Segmented by Usage, US, 2004 and 2009

Exhibit 7-5: Nasal Spray Device Market, US, 2003-009 (Tabular Format)

Exhibit 7-6: Nasal Spray Device Market, US, 2003-009 (Graphical Format)

Exhibit 7-7: Nasal Spray Technology Market, US, 2003-009 (Tabular Format)

Exhibit 7-8: Nasal Spray Technology Market, US, 2003-009 (Graphical Format)

Exhibit 7-9: Nasal Transmucosal Market, Device and Technology, US, 2003-009 (Tabular Format)

Exhibit 7-10: Nasal Transmucosal Market, Device and Technology, US, 2003-009 (Graphical Format)

Exhibit 7-11: Routes of Nasal Delivery

Exhibit 7-12: Drivers and Limiters of the Transmucosal Market, US

Exhibit 7-13: Leading Competitors in the Nasal Spray Device Market, US, 2004 (Tabular Format)

Exhibit 7-14: Leading Competitors in the Nasal Spray Device Market, US, 2004 (Graphical Format)

Chapter 8: Oral Delivery

Exhibit 8-1: Oral Delivery Market, US, 2003-009

Exhibit 8-2: Oral Delivery Market, Segmented by Technology, US, 2003-009 (Tabular Format)

Exhibit 8-3: Oral Delivery Market, Segmented by Technology, US, 2003-009 (Graphical Format)

Exhibit 8-4: Oral Delivery Market, Segmented by Technology and Pharmaceutical, US, 2003-009 (Tabular Format)

Exhibit 8-5: Oral Delivery Market, Segmented by Technology and Pharmaceutical, US, 2003-009 (Graphical Format)

Exhibit 8-6: Oral Sustained Release Market, Segmented by Technology and Pharmaceutical, US, 2003-009 (Tabular Format)

Exhibit 8-7: Oral Sustained Release Market, US, 2003-009

Exhibit 8-8: Oral Sustained Release Market, Segmented by Technology and Pharmaceutical, US, 2003-009 (Graphical Format)

Exhibit 8-9: Oral Fast-Dissolve Market, Segmented by Technology and Pharmaceutical, US, 2003-009 (Tabular Format)

Exhibit 8-10: Oral Fast-Dissolve Market, US, 2003-009

Exhibit 8-11: Oral Fast-Dissolve Market, Segmented by Technology and Pharmaceutical, US, 2003-009 (Graphical Format)

Exhibit 8-12: Drivers and Limiters of the Oral Delivery Market, US

Exhibit 8-13: Oral Delivery Companies, US, 2004

Chapter 9: Emerging Technology

Exhibit 9-1: Solubilization Technologies under Development by SkyePharma

Exhibit 9-2: Inhaled Insulin Products

Exhibit 9-3: Insulin Delivery Market, US, 2004

Exhibit 9-4: Insulin Delivery Market, US, 2009

Exhibit 9-5: Insulin Delivery Users, US, 2004 and 2009

Exhibit 9-6: Insulin Delivery Market Value, US, 2004 and 2009

Exhibit 9-7: DUROS Products Currently in Development

Exhibit 9-8: Selected Competitors with Emerging Technologies, US, 2004

Appendix A

Exhibit A-1: MRG Acronyms and Initialisms